logo
Radian Group (NYSE:RDN) Misses Q2 Revenue Estimates

Radian Group (NYSE:RDN) Misses Q2 Revenue Estimates

Yahoo30-07-2025
Mortgage insurance provider Radian Group (NYSE:RDN) fell short of the market's revenue expectations in Q2 CY2025, with sales flat year on year at $318 million. Its non-GAAP profit of $1.01 per share was 3.6% above analysts' consensus estimates.
Is now the time to buy Radian Group? Find out in our full research report.
Radian Group (RDN) Q2 CY2025 Highlights:
Net Premiums Earned: $237.5 million (flat year on year)
Revenue: $318 million vs analyst estimates of $324.2 million (flat year on year, 1.9% miss)
Pre-Tax Profit Margin: 55% (3.5 percentage point year-on-year decrease)
Adjusted EPS: $1.01 vs analyst estimates of $0.98 (3.6% beat)
Market Capitalization: $4.56 billion
'We reported strong performance for Radian in the second quarter, increasing book value per share by 12% year-over-year, generating net income of $142 million and delivering a return on equity of 12.5%. Our primary mortgage insurance in force, a key driver of future earnings for our company, grew to another all-time high of $277 billion,' said Radian's Chief Executive Officer Rick Thornberry.
Company Overview
Founded during the housing boom of 1977 and weathering multiple real estate cycles since, Radian Group (NYSE:RDN) provides mortgage insurance and real estate services, helping lenders manage risk and homebuyers achieve affordable homeownership.
Revenue Growth
Insurers earn revenue three ways. The core insurance business itself, often called underwriting and represented in the income statement as premiums earned, is one way. Investment income from investing the 'float' (premiums collected upfront not yet paid out as claims) in assets such as fixed-income assets and equities is the second way. Fees from various sources such as policy administration, annuities, or other value-added services is the third.
Over the last five years, Radian Group's demand was weak and its revenue declined by 2.5% per year. This wasn't a great result and suggests it's a low quality business.
We at StockStory place the most emphasis on long-term growth, but within financials, a half-decade historical view may miss recent interest rate changes, market returns, and industry trends. Radian Group's annualized revenue growth of 3.1% over the last two years is above its five-year trend, but we were still disappointed by the results.
Note: Quarters not shown were determined to be outliers, impacted by outsized investment gains/losses that are not indicative of the recurring fundamentals of the business.
This quarter, Radian Group missed Wall Street's estimates and reported a rather uninspiring 1% year-on-year revenue decline, generating $318 million of revenue.
Net premiums earned made up 76.9% of the company's total revenue during the last five years, meaning insurance operations are Radian Group's largest source of revenue.
While insurers generate revenue from multiple sources, investors view net premiums earned as the cornerstone - its direct link to core operations stands in sharp contrast to the unpredictability of investment returns and fees.
Software is eating the world and there is virtually no industry left that has been untouched by it. That drives increasing demand for tools helping software developers do their jobs, whether it be monitoring critical cloud infrastructure, integrating audio and video functionality, or ensuring smooth content streaming. Click here to access a free report on our 3 favorite stocks to play this generational megatrend.
Book Value Per Share (BVPS)
Insurance companies are balance sheet businesses, collecting premiums upfront and paying out claims over time. The float–premiums collected but not yet paid out–are invested, creating an asset base supported by a liability structure. Book value per share (BVPS) captures this dynamic by measuring these assets (investment portfolio, cash, reinsurance recoverables) less liabilities (claim reserves, debt, future policy benefits). BVPS is essentially the residual value for shareholders.
We therefore consider BVPS very important to track for insurers and a metric that sheds light on business quality. While other (and more commonly known) per-share metrics like EPS can sometimes be lumpy due to reserve releases or one-time items and can be managed or skewed while still following accounting rules, BVPS reflects long-term capital growth and is harder to manipulate.
Radian Group's BVPS grew at a solid 9.8% annual clip over the last five years. BVPS growth has also accelerated recently, growing by 11.9% annually over the last two years from $26.51 to $33.18 per share.
Key Takeaways from Radian Group's Q2 Results
Radian's revenue missed and its net premiums earned fell slightly short of Wall Street's estimates, which wasn't a good start. On the other hand, EPS beat. Overall, this was a mixed quarter. The stock remained flat at $33.51 immediately after reporting.
The latest quarter from Radian Group's wasn't that good. One earnings report doesn't define a company's quality, though, so let's explore whether the stock is a buy at the current price. If you're making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here, it's free.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why Medtronic (MDT) is a Top Value Stock for the Long-Term
Why Medtronic (MDT) is a Top Value Stock for the Long-Term

Yahoo

timean hour ago

  • Yahoo

Why Medtronic (MDT) is a Top Value Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics. Why Investors Should Pay Attention to This Value Stock Finding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, and Price/Cash Flow to highlight the most attractive and discounted stocks. Medtronic (MDT) In 2015, Medtronic, Inc. (the legacy NYSE-listed parent company, incorporated in Minnesota) acquired Ireland-based Covidien plc for cash and stock of $49.9 billion. The acquisition resulted in the formation of a new holding company incorporated in Ireland called Medtronic plc (the new Irish tax resident, NYSE-listed parent company holding both the legacy Medtronic and Covidien). MDT sits at a Zacks Rank #3 (Hold), holds a Value Style Score of B, and has a VGM Score of B. Compared to the Medical - Products industry's P/E of 18.5X, shares of Medtronic are trading at a forward P/E of 16.2X. MDT also has a PEG Ratio of 2.3, a Price/Cash Flow ratio of 11.6X, and a Price/Sales ratio of 3.4X. Value investors don't just pay attention to a company's valuation ratios; positive earnings play a crucial role, too. Two analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0 to $5.55. MDT has an average earnings surprise of 2.2%. With strong valuation and earnings metrics, a good Zacks Rank, and top-tier Value and VGM Style Scores, investors should strongly think about adding MDT to their portfolios. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Medtronic PLC (MDT) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

Ketjen Introduces New Breakthrough Catalyst Technology that Effectively Mitigates the Effects of Iron Poisoning in FCC Units
Ketjen Introduces New Breakthrough Catalyst Technology that Effectively Mitigates the Effects of Iron Poisoning in FCC Units

Yahoo

timean hour ago

  • Yahoo

Ketjen Introduces New Breakthrough Catalyst Technology that Effectively Mitigates the Effects of Iron Poisoning in FCC Units

Commercial trial demonstrates SaFeGuard's™ effectiveness in processing opportunity crudes HOUSTON, August 20, 2025--(BUSINESS WIRE)--Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing has launched SaFeGuard™, a new catalyst technology designed to address iron (Fe) poisoning in FCC units. In a recent 30-day full commercial trial, SaFeGuard™ demonstrated a 77% improvement in accessibility with a 50% inventory replacement enabling an increase in unit activity, improved bottoms cracking, and ability to process heavy iron-rich feedstocks. Further testing and predictive modeling suggest that a full 100% inventory changeout could yield up to a 130% increase in accessibility delivering additional improvement in performance. SaFeGuard™ delivers a step change in the contaminant Fe and calcium (Ca) tolerance window by minimizing the Eutectic formation, thereby keeping catalyst pores open. This enables higher activity levels and furthers bottoms cracking, ultimately uplifting profit margins. "We've developed a powerful, safe and sustainable solution that addresses iron poisoning and will increase profitability for our customers by allowing for lower-cost feeds and more efficient operations," said Ketjen's Chief Commercial Officer Henri Tausch. "This new technology is the culmination of decades of research aimed at developing industry leading iron and calcium tolerant catalysis and illustrates our commitment to developing innovative solutions that support the evolving needs of our customers." "SaFeGuard™ is a great option for refiners who are taking advantage of opportunity crudes and even bio feeds because it is just as effective in combating additional contaminants including nickel, vanadium, calcium, sodium, and silicon," said David Leach, Vice President and General Manager, FCC at Ketjen. "It can be used to process iron-rich feedstocks including heavy, resid, tight oil and renewable feeds, and it's also great for units facing accessibility limitations because it requires less frequent catalyst replacement." Ketjen's next generation SaFeGuard™ technology is currently available for use by refiners around the globe. Contact us to learn more about how you can unlock the full potential of your FCC unit. About Ketjen Ketjen is a provider of advanced catalyst solutions to leading producers in the petrochemical, refining and specialty chemicals industries. From fluidized catalytic cracking to clean fuels solutions to hydro-processing to organometallics and curatives, Ketjen delivers safe and reliable solutions that increase production performance and business value. A wholly owned subsidiary of Albemarle Corporation (NYSE: ALB), Ketjen Corporation is headquartered in Houston, Texas, and serves global customers through operations in 25 markets. For more information, visit View source version on Contacts Media Contact: Jennifer Albert, MediaRelations@ Sign in to access your portfolio

IonQ Expands Quantum IP Portfolio, Surpassing 1,000 Patents And Applications
IonQ Expands Quantum IP Portfolio, Surpassing 1,000 Patents And Applications

Yahoo

timean hour ago

  • Yahoo

IonQ Expands Quantum IP Portfolio, Surpassing 1,000 Patents And Applications

IonQ, Inc. (NYSE:IONQ) announced major progress in its intellectual property (IP) strategy on Wednesday. The company's shares fell, weighed down by broader tech sector weakness, despite positive announcements on its IP. The quantum computing firm revealed it has been granted new U.S. patents, broadening its portfolio and reinforcing its leadership in trapped-ion quantum company now controls or has access to more than 1,000 patents and applications across its business lines, showcasing the depth of its IP. These additions are expected to strengthen IonQ's ability to scale technology, boost performance, and enhance its commercial edge in the rapidly growing quantum computing sector. IonQ executives said the expanded portfolio reflects a long-term strategy to secure breakthrough technologies in quantum computing. Chairman and CEO Niccolo de Masi emphasized that the new patents will help accelerate the development of scalable, efficient quantum systems, moving the industry closer to commercial quantum advantage. The latest patents cover improvements in areas such as gate operations, noise reduction, error mitigation, and circuit optimization. Highlights include a patent for a portable quantum memory package designed to support secure, long-distance quantum communications, and another for a self-aligning fabrication process that improves photonic waveguide coupling in memory devices. Dean Kassmann, IonQ's SVP of Engineering & Technology, said the new intellectual property underscores the company's technical leadership. He noted that IonQ's R&D team continues to deliver innovations that bring enterprise-grade systems closer to surpassing classical computing. IonQ aims to build a quantum system with 2 million qubits by 2030. Such advancements could transform industries including pharmaceuticals, materials science, logistics, defense, and financial services. Customers and partners already include Inc.'s (NASDAQ:AMZN) Amazon Web Services, AstraZeneca Plc (NASDAQ:AZN), and NVIDIA Corp. (NASDAQ:NVDA). According to Benzinga Pro, IONQ stock has gained over 400% in the past year. Investors can gain exposure to the stock via Tidal Trust II YieldMax Ultra Option Income Strategy ETF (NYSE:ULTY). Price Action: IONQ stock is trading lower by 1.29% to $36.33 at last check Wednesday. Read Next:Image via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article IonQ Expands Quantum IP Portfolio, Surpassing 1,000 Patents And Applications originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store